Kairos Pharma KAPA
NYSE KAPA
$0.54 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Kairos Pharma (KAPA) Return on Capital Employed [ROCE] (2024 - 2025)

Updated

Kairos Pharma (KAPA) reported Return on Capital Employed [ROCE] of -93.57% for FY2025, up 5.10 percentage points from -98.67% in FY2024.

Analysis

Kairos Pharma (KAPA) Return on Capital Employed [ROCE] (2024 - 2025) Analysis & Trends

  • According to Business Quant data, Return on Capital Employed [ROCE] came in at -98.67% in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.52%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 17.92%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 6.28%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 19.32%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 16.76%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 16.66%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -5.97%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.86%
10 Kairos Pharma 11.24 Mn -1.17 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -68.65%
Mar 31, 2025 -54.85%
Dec 31, 2024 -53.21%
API Access

Kairos Pharma Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=KAPA&period=max&api_key=YOUR_API_KEY